The study of human CARD9 deficiency has yielded novel insights into how this adaptor signaling molecule functions to protect against invasive fungal diseases and, importantly, these findings point to potential new avenues for the development of immune-based treatments for invasive fungal infections, which represent a global clinical challenge. This evidence concerns the gene CARD9 and fungal infectious disease.